secwatch.observer — SEC 8-K summary
======================================

Issuer:     Novo Integrated Sciences, Inc. (—)
CIK:        0001138978
Form:       8-K
Filed at:   2024-04-15T23:59:59+00:00
Accession:  0001493152-24-014626
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Novo Integrated Sciences Q2 revenue up 24% to $3.17M, net loss down 41% to $2.75M
--------------------------------------------------------------------------------

- Revenue $3,170,592, +24% YoY, driven by product sales increase.
- Net loss $2,746,128, -41% YoY, due to higher gross profit and lower other expenses.
- Cash $651,747; total assets $34,949,271; equity $21,890,284 at Feb 29, 2024.
- $449,535 Mast Hill Fund promissory note converted to 457,128 shares in Dec 2023.
- CEO cites focus on operational efficiencies and seeks new financing to accelerate growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1138978/000149315224014626/0001493152-24-014626-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1138978/000149315224014626/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-014626

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer